Today, 28 July 2026, the Champalimaud Foundation and the NOVA University Lisbon signed a five-year strategic partnership agreement focused on scientific research, advanced training and technological innovation, further strengthening collaboration between the two institutions.

The agreement establishes the foundations for joint research and development projects in the areas of health, life sciences and innovation. The aim is to share knowledge, expertise and specialised resources between the two institutions, accelerating the development of new solutions. 

To us, Tonegawa was not only a giant of world science, he was also a cherished friend of the Champalimaud  Foundation.

Present from the Champalimaud Foundation's earliest and most formative years, he helped shape its scientific DNA, contributing to the model that continues to guide us today: science that is ambitious, rigorous and committed to making a real difference to people's lives. 

The Robotic Surgery Room combines advanced technology and specialised clinical expertise to support the treatment of cancer patients with exceptional precision and control.

Equipped with a state-of-the-art robotic surgical system, this space enables highly trained surgeons to perform complex surgeries with enhanced accuracy, helping to optimize tumour removal while preserving healthy tissue whenever possible.

Offer Description

Seeking a dedicated Cell Culture Research Technician to join our dynamic team to advance medical knowledge and make a positive impact on healthcare.

Main duties will include: 

Offer Description

The Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a Postdoctoral Researcher to join the Surgery, Care, Outcomes, Personalization, and Empowerment (SCOPE) Lab, within the Breast Cancer Research Programme.
 

The Champalimaud Foundation is excited to announce the upcoming course, Pathology Updates 2026, which will be held on September 21st-23rd in the Seminar Room. This course is organised in partnership with Mayo Clinic Scottsdale and Rochester. The 2026 edition marks its 6th iteration and the 3rd to be hosted at the Champalimaud Foundation.

Published in The Breast, the technical pilot study describes the development and feasibility of an augmented reality-guided system for non-invasive tumour localisation. The work is the result of several years of research led by Tiago Marques, Pedro Gouveia and João Santinha, Group Leaders of the Digital Surgery Lab (DSL) together with several team members such as the PhD student Rafaela Timóteo who helped on the project development as well as data acquisition and analysis.

Host

Carlos Minutti, PhD, Immunoregulation Lab

Venue

Seminar Room

Since 2021, CNM has been fostering scientific curiosity, confidence and empowerment among students from underserved communities across the Greater Lisbon area through hands-on experiences, meaningful interactions with researchers and sustained mentoring relationships. 

A legacy that changed rectal cancer

When Professor Heald first described TME, local recurrence rates after rectal cancer surgery in many centres were 20-30%, with devastating consequences for patients. By insisting on meticulous, sharp dissection in the “holy plane”, respecting embryology and removing the mesorectum as an intact package, he showed that local recurrence could be reduced to single digits, with corresponding gains in survival and function.